Omeros Revenue, Growth & Competitor Profile

Company Profile & Annual Report for Omeros

Access the complete profile.

Omeros Fast Facts

Revenue	$10 - $100 million    See Exact Annual Revenue
Employees	100 - 500Exact Company Size
Primary Industry	5417 Scientific Research & Development Services
Additional NAICS Codes	325412 Pharmaceutical Preparation Manufacturing 541711 Research & Development in Biotechnology
Address	201, Elliott Avenue West Seattle, WA 98119

Note: Revenues for privately held companies are statistical evaluations.


Omeros's Annual Report & Profile shows critical firmographic facts:

• What is the company's size? (Annual sales and employees)
  • Omeros's annual revenues are $10 - $100 million (see exact revenue data)
• What industry is the company in?
  • Omeros is classified as operating in the Scientific Research & Development Services industry, NAICS Code 5417.

Omeros Annual Revenue and Growth Rate

Omeros	Revenue Est. ($ Million)	Growth Rate (%)	# Employees
2025	$10 - $100 million Details in Premium Report
2024
2023
2021
2020
2019

1-Year Growth Rate: 3-Year Growth Rate (CAGR):

Note: Omeros's revenues are gauged from an analysis of company filings.

Omeros's Income Statement (based on Industry Averages)

Omeros P&L	$ Millions
Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit

Trademark Applications

Trademark applications show the products and services that Omeros is developing and marketing. Omeros doesn't have any recent trademark applications, indicating Omeros is focusing on its existing business rather than expanding into new products and markets. Trademarks may include brand names, product names, logos and slogans.

Trademark	Date
OMLEYA Pharmaceutical preparations for the treatment of endothelial diseases and disorders, renal diseases, transplant complications, ischemia-reperfusion injury and hematological, autoimmune, neurological, immunological and inflammation-related disease and disorders; biologics for the treatment of endothelial diseases and disorders, renal diseases, transplant complications, ischemia-reperfusion injury and hematological, autoimmune, neurological, immunological and inflammation-related disease and disorders	05/25/2023
T-CAM Providing medical information	02/14/2023
YARTEMLEASSIST PATIENT SUPPORT PROGRAM Educational services, namely, conducting educational programs in the fields of endothelial diseases and disorders, renal diseases, transplant complications, ischemia-reperfusion injury and hematological, autoimmune, neurological, immunological and inflammation-related disease and disorders and treatment and patient support options for these conditions	06/16/2022

See all trademarks and details in the Full Report.

Market Share of Omeros's Largest Competitors

A competitive analysis shows these companies are in the same general field as Omeros, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company	Headquarters	Revenue ($ MM)
LEIDOS	Denver, CO	100
NATIONAL TECHNOLOGY & ENGINEERING SOLUTIONS OF SANDIA	Albuquerque, NM	30
INC RESEARCH	Raleigh, NC	27
RESEARCH FOUNDATION FOR STATE UNIVERSITY OF NEW YORK	Albany, NY	17
FLUOR MARINE PROPULSION	West Mifflin, PA	15
SYNEOS HEALTH	Raleigh, NC	13
ILLUMINA	San Diego, CA	12
UT-BATTELLE	Oak Ridge, TN	11
PRA HOLDINGS	Raleigh, NC	11

Nearby Competitors

These companies are similar in business line and location to Omeros. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company	Headquarters	Revenue ($ MM)
FRED HUTCHINSON CANCER CENTER	Seattle, WA	100
ADAPTIVE BIOTECHNOLOGIES	Seattle, WA	14
ALLEN INSTITUTE	Seattle, WA	13
JUNO THERAPEUTICS	Seattle, WA	13
SANA BIOTECHNOLOGY	Seattle, WA	9
ULTRA SAFE NUCLEAR	Seattle, WA	5

Future Competition: Omeros's Fastest Growing Competitors

These companies are in the same general field as Omeros and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

Company	Revenue ($ MM)